National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 903095

Government Disclaimer on use of this data

Case Details

VAERS ID: 903095 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: Oklahoma  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private       Purchased by: ?
Symptoms: Blood pressure increased, Chest discomfort, Dizziness, Heart rate increased, Hyperhidrosis
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Hypertension (narrow), Vestibular disorders (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Gabapentin, escitalopram, hydroxychloroquine, Breo Ellipta, Singulair, Celebrex, Lyrica
Current Illness:
Preexisting Conditions: Asthma Rheumatoid arthritis
Allergies: Sulfa allergy
Diagnostic Lab Data:
CDC Split Type:

Write-up: Approximately 10 minutes after receiving the vaccine in the left arm, the patient began feeling lightheaded and had some chest heaviness. They became diaphoretic and at this point blood pressure and heart rate were checked. HR was elevated to 90 bpm from patient''s baseline of approximately 60-65 bpm. Blood pressure was elevated at 150/100 mmHg. Pt was provided water and symptoms resolved. Patient was monitored an additional 30 minutes and did not have any recurrence of symptoms. Blood pressure and heart rate returned to baseline.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166